|
Volumn 118, Issue , 2013, Pages 185-189
|
Decrease in the apparent diffusion coefficient in peritumoral edema for the assessment of recurrent glioblastoma treated by bevacizumab.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
DIAGNOSTIC AGENT;
GADOLINIUM;
MONOCLONAL ANTIBODY;
ARTICLE;
BRAIN CIRCULATION;
BRAIN EDEMA;
BRAIN TUMOR;
DIFFUSION;
DRUG EFFECT;
GLIOBLASTOMA;
HUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PHYSIOLOGY;
TIME;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
BRAIN EDEMA;
BRAIN NEOPLASMS;
CEREBROVASCULAR CIRCULATION;
DIFFUSION;
GADOLINIUM;
GLIOBLASTOMA;
HUMANS;
MAGNETIC RESONANCE IMAGING;
TIME FACTORS;
|
EID: 84881345037
PISSN: 00651419
EISSN: None
Source Type: None
DOI: 10.1007/978-3-7091-1434-6_34 Document Type: Article |
Times cited : (23)
|
References (0)
|